Interaction between oxidative stress and γ-linolenic acid in impaired neurovascular function of diabetic rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 3 34-3, 1996, Pages

  Cameron, Norman E ^a   Cotter, Mary A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

antioxidant; blood flow; essential fatty acid; nerve conduction; oxygen free radical; prostanoid

Indexed keywords

ANTIOXIDANT; ESSENTIAL FATTY ACID; FREE RADICAL; GAMMA LINOLENIC ACID; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; ENDONEURIUM; ENZYME INHIBITION; EXPERIMENTAL DIABETES MELLITUS; GLYCOSYLATION; HYPERGLYCEMIA; MOLECULAR INTERACTION; MOTOR NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

EID: 0029848874     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.3.e471     Document Type: Article

References (33)

1. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624, 1990.
2. Botting, R., and J. R. Vane. Mediators and anti-thrombotic properties of the vascular endothelium. Ann. Med. 21: 31-38, 1989.
3. Cameron, N. E., and M. A. Cotter. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway activity. Diabetologia 35: 1011-1019, 1992.
4. Cameron, N. E., and M. A. Cotter. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab. Rev. 10: 189-224, 1994.
5. Cameron, N. E., and M. A. Cotter. Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats. Acta Diabetologica 31: 220-225, 1994.
6. Cameron, N. E., and M. A. Cotter. Neurovascular dysfunction in diabetic rats; potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J. Clin. Invest. 96: 1159-1163, 1995.
7. Cameron, N. E., and M. A. Cotter. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 352: 685-690, 1995.
8. Cameron, N. E., M. A. Cotter, V. Archibald, K. C. Dines, and E. K. Maxfield. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37: 449-459, 1994.
9. Cameron, N. E., M. A. Cotter, K. C. Dines, and E. K. Maxfield. Pharmacological manipulation of vascular endothelium in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36: 516-522, 1993.
10. Cameron, N. E., M. A. Cotter, K. C. Dines, E. K. Maxfield, F. Carey, and D. J. Mirrlees. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Diabetologia 37: 651-663, 1994.
11. Cameron, N. E., M. A. Cotter, and T. C. Hohman. Interaction between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 39: 172-182, 1996.
12. Cameron, N. E., M. A. Cotter, and P. A. Low. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E1-E8, 1991.
13. Cameron, N. E., M. A. Cotter, and S. Robertson. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q. J. Exp. Physiol. 74: 917-926, 1989.
14. Cameron, N. E., M. A. Cotter, and S. Robertson. Essential fatty acid diet supplementation: effects on peripheral nerve and skeletal muscle function and capillarization in streptozotocin-induced diabetic rats. Diabetes 40: 532-539, 1991.
15. Ceriello, A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36: 1119-1125, 1993.
16. Ceriello, A., D. Guigliano, A. Quatraro, and P. J. Lefebvre. Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin. Sci. Lond. 81: 739-742, 1991.
17. Cotter, M. A., A. Love, M. J. Watt, N. E. Cameron, and K. C. Dines. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38: 1285-1294, 1995.
18. Dines, K. C., N. E. Cameron, and M. A. Cotter. Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats. J. Pharmacol. Exp. Ther. 273: 49-55, 1995.
19. Dines, K. C., M. A. Cotter, and N. E. Cameron. Contrasting effects of treatment with ω-3 and ω-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia 36: 1132-1138, 1993.
20. Fruebis, J., S. Steinberg, H. A. Dresel, and T. E. Carew. A comparison of the antiatherogenic effects of probucol and a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J. Clin. Invest. 94: 392-398, 1994.
21. Karasu, C., M. Dewhurst, E. J. Stevens, and D. R. Tomlinson. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia 38: 129-134, 1995.
22. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37: 264-269, 1994.
23. Keegan, A., H. Walbank, M. A. Cotter, and N. E. Cameron. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 38: 1475-1478, 1995.
24. Keen, H., J. Payan, J. Allawi, J. Walker, G. A. Jamal, A. I. Weir, L. M. Henderson, E. A. Bissessar, P. J. Watkins, M. Sampson, E. A. M. Gale, J. Scarpello, H. G. Boddie, K. J. Hardy, P. K. Thomas, P. Misra, and J. P. Halonen. Treatment of diabetic neuropathy with γ-linolenic acid. Diabetes Care 16: 8-15, 1993.
25. Kihara, M., and P. A. Low. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol. 132: 180-185, 1995.
26. Kihara, M., P. J. Zollman, I. L. Smithson, T. D. Lagerlund, and P. A. Low. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E980-E985, 1994.
27. Kunusaki, M., F. Umeda, T. Inoguchi, and H. Nawata. Vitamin E restores reduced prostacyclin synthesis in aortic endothelial cells cultured with a high concentration of glucose. Metab. Clin. Exp. 41: 613-621, 1992.
28. Low, P. A., T. D. Lagerlund, and P. G. McManis. Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31: 355-438, 1989.
29. 1 receptor antagonist. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E530-E537, 1995.
30. Nickander, K. K., J. D. Schmelzer, D. A. Rohwer, and P. A. Low. Effects of α-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J. Neurol. Sci. 126: 6-14, 1994.
31. Tesfaye, S., R. Malik, and J. D. Ward. Vascular factors in diabetic neuropathy. Diabetologia 37: 847-854, 1994.
32. Ward, K. K., P. A. Low, J. D. Schmelzer, and D. W. Zochodne. Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 112: 197-208, 1989.
33. Zhu, X., and J. Eichberg. Molecular species composition of glycerophospholipids in rat sciatic nerve and its alteration in streptozotocin-induced diabetes. Biochim. Biophys. Acta 1168: 1-12, 1993.